Zobrazeno 1 - 10
of 622
pro vyhledávání: '"Isao sakaida"'
Autor:
Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Naoko Okayama, Mitsuaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki
Publikováno v:
Liver Cancer (2024)
Background: Patients with hepatitis virus-related hepatocellular carcinoma (viral HCC) are decreasing as hepatitis control improves, but those with non-viral-related HCC (non-viral HCC) are increasing in Japan. No established surveillance system exis
Externí odkaz:
https://doaj.org/article/a0703f6b2ca94c5297d352e3e8d34602
Autor:
Toshihiko Matsumoto, Shuji Terai, Toshiyuki Oishi, Shinya Kuwashiro, Koichi Fujisawa, Naoki Yamamoto, Yusuke Fujita, Yoshihiko Hamamoto, Makoto Furutani-Seiki, Hiroshi Nishina, Isao Sakaida
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 7 (2023)
Externí odkaz:
https://doaj.org/article/879bdce8d28748eb9bd847620008f9bf
Autor:
Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12885-023-11677-6.
Externí odkaz:
https://doaj.org/article/1da1f8b04d04465d9c5d3eafd55e5734
Autor:
Koichi Fujisawa, Taro Takami, Toshihiko Matsumoto, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
Cancer & Metabolism, Vol 10, Iss 1, Pp 1-11 (2022)
Abstract Background Although iron chelation has garnered attention as a novel therapeutic strategy for cancer, higher levels of efficacy need to be achieved. In the present study, we examined the combinatorial effect of deferoxamine (DFO), an iron ch
Externí odkaz:
https://doaj.org/article/617732e7fab8407dbd312e174a5c4347
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
Autor:
Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/4c91c6176aba4c23b8f184812284224b
Autor:
Koichi Fujisawa, Taro Takami, Haruko Shintani, Nanami Sasai, Toshihiko Matsumoto, Naoki Yamamoto, Isao Sakaida
Publikováno v:
FEBS Open Bio, Vol 11, Iss 4, Pp 1029-1040 (2021)
Organisms living in temperate regions are sensitive to seasonal variations in the environment; they are known to accumulate energy as fat in their livers during the winter when days are shorter, temperatures are lower, and food is scarce. However, th
Externí odkaz:
https://doaj.org/article/49d91f5eca4247848c84ed1960d90db2
Autor:
Takuro Hisanaga, Isao Hidaka, Isao Sakaida, Nobuaki Nakayama, Akio Ido, Naoya Kato, Yasuhiro Takikawa, Kazuaki Inoue, Masahito Shimizu, Takuya Genda, Shuji Terai, Hirohito Tsubouchi, Hajime Takikawa, Satoshi Mochida, Intractable Hepato‐Biliary Disease Study Group of Japan
Publikováno v:
JGH Open, Vol 5, Iss 4, Pp 428-433 (2021)
Abstract Background and Aim In Japan, corticosteroids have been commonly used as a part of multidisciplinary therapy for patients with acute liver failure and late‐onset hepatic failure. However, there is controversy regarding the development of in
Externí odkaz:
https://doaj.org/article/0d4366d872a644fdb3f7e6e505aa7ffc
Autor:
Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have reported, through in
Externí odkaz:
https://doaj.org/article/c1683f28e4d9499f8dfec2adba05ea0c
Autor:
Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki
Publikováno v:
Hepatology Communications, Vol 4, Iss 3, Pp 461-470 (2020)
Liquid biopsies are not used in practice for hepatocellular carcinoma (HCC). Epi proColon is the first commercial blood‐based test for colorectal cancer screening based on methylated DNA testing of the septin 9 gene (SEPT9). However, Epi proColon h
Externí odkaz:
https://doaj.org/article/469eeeaaf6aa49a6a95a3763152dae62
Autor:
Takahiro Yamasaki, Issei Saeki, Yurika Yamauchi, Toshihiko Matsumoto, Yutaka Suehiro, Tomokazu Kawaoka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Kazufumi Kobayashi, Takayuki Kondo, Sadahisa Ogasawara, Tetsuhiro Chiba, Taro Takami, Kazuaki Chayama, Naoya Kato, Isao Sakaida
Publikováno v:
Liver Cancer (2022)
Background: Sarcopenia, defined as the loss of skeletal muscle mass, physical performance, and strength, has been associated with poor clinical outcomes in hepatocellular carcinoma (HCC) patients treated with several therapies. As systemic therapies,
Externí odkaz:
https://doaj.org/article/6e2cdf26529e4ee499416fc78b0b17e8